Stonepine Capital Management as of March 31, 2021
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 29 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amryt Pharma Sponsored Ads | 19.0 | $35M | 2.5M | 13.93 | |
| Adamas Pharmaceuticals | 8.9 | $16M | 3.4M | 4.80 | |
| Chiasma | 8.4 | $16M | 4.9M | 3.13 | |
| Catalyst Biosciences Com New | 6.7 | $12M | 2.5M | 5.04 | |
| Kalvista Pharmaceuticals (KALV) | 5.9 | $11M | 422k | 25.69 | |
| Ovid Therapeutics (OVID) | 5.4 | $10M | 2.5M | 4.02 | |
| Cti Biopharma | 5.2 | $9.6M | 3.3M | 2.91 | |
| Diamedica Therapeutics Com New (DMAC) | 5.1 | $9.4M | 1.0M | 9.15 | |
| Affimed Therapeutics B V | 4.4 | $8.1M | 1.0M | 7.91 | |
| Apollo Endosurgery | 4.3 | $8.0M | 1.4M | 5.51 | |
| Xoma Corp Com New (XOMA) | 3.6 | $6.7M | 163k | 40.81 | |
| Yumanity Therapeutics | 3.3 | $6.1M | 336k | 18.10 | |
| Iveric Bio | 2.9 | $5.4M | 875k | 6.18 | |
| Plx Pharma | 2.5 | $4.6M | 506k | 9.03 | |
| Conformis | 2.4 | $4.4M | 4.4M | 0.99 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.8 | $3.3M | 329k | 10.16 | |
| Exagen (XGN) | 1.8 | $3.3M | 191k | 17.50 | |
| Aytu Biopharma Com New | 1.5 | $2.8M | 363k | 7.60 | |
| Angion Biomedica Corp | 1.3 | $2.4M | 135k | 18.07 | |
| Gamida Cell SHS (GMDA) | 1.1 | $2.0M | 245k | 8.09 | |
| Celcuity (CELC) | 0.8 | $1.6M | 109k | 14.34 | |
| Contrafect Corp Com New | 0.7 | $1.3M | 269k | 4.80 | |
| Strongbridge Biopharma Shs Usd | 0.7 | $1.2M | 446k | 2.76 | |
| Aptevo Therapeutics Com New | 0.6 | $1.2M | 39k | 30.52 | |
| Corvus Pharmaceuticals (CRVS) | 0.5 | $974k | 316k | 3.08 | |
| Applied Genetic Technol Corp C | 0.5 | $910k | 180k | 5.07 | |
| Galapagos Nv Spon Adr (GLPG) | 0.4 | $771k | 10k | 77.10 | |
| Brainsway Sponsored Ads (BWAY) | 0.3 | $498k | 55k | 9.02 | |
| Oncosec Medical Incorporated | 0.2 | $452k | 95k | 4.77 |
